HWM vs IKT · P/E 58, rev $4.86B vs $215.2M cap
Howmet Aerospace Inc (HWM) versus Inhibikase Therapeutics Inc (IKT) — a side-by-side from cached financials, not a winner call.
Howmet Aerospace Inc (HWM) is a aerospace & defense company listed on US.
Inhibikase Therapeutics Inc (IKT) is a biotechnology company listed on US.
Latest reported HWM revenue for 2026-06-30 was $4.86B. Net income was $1.11B. HWM currently screens at market cap $100.79B and trailing P/E 58.4.
Latest reported IKT revenue for 2026-06-30 was $0. Net income was -$36.0M. IKT currently screens at market cap $215.2M.
HWM currently screens at market cap $100.79B and trailing P/E 58.4. IKT currently screens at market cap $215.2M.
Not investment advice. Open the HWM and IKT stock pages for the full models.
Not investment advice.